Skip to main content
Veterinary Medicines

Advantage 40 mg Lösung zum Auftropfen für Hunde (< 4 kg)

Authorised
  • Imidacloprid

Product identification

Medicine name:
Advantage 40 mg Lösung zum Auftropfen für Hunde (< 4 kg)
Advantage 40 mg Lösung zum Auftropfen für Hunde (<4kg)
Active substance:
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    40.00
    milligram(s)
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Cutaneous solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Pack sizes 0.4 ml solution per pipette, Pack containing 1 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 2 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 3 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 4 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 6 unit dose pipettes, Container: White polypropylene pipettes with caps

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 400172.00.00
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0020/001
Concerned member states:
  • Denmark
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 12/08/2025